Changeflow GovPing Pharma & Drug Safety UV-Absorbing Emulsion with Physical UV-Attenuat...
Routine Notice Added Final

UV-Absorbing Emulsion with Physical UV-Attenuating Material, Surfactant, and Thickener

Favicon for changeflow.com USPTO Patent Applications - Pharma (A61K)
Published
Detected
Email

Summary

USPTO published L'OREAL's patent application (US20260096964A1) for UV-absorbing emulsion compositions containing physical UV-attenuating material, surfactant, and thickening agents. The application was filed on October 4, 2024, under Application No. 18906424. Inventors include Anil Shah, David Enoch Gee II, Brian Bodnar, and Margaret Kindschuh.

This patent publication affects cosmetics and personal care product manufacturers developing UV-protective formulations. Companies should review the claims to assess potential overlap with their own product development pipelines and IP strategies.

What changed

USPTO published L'OREAL's patent application (US20260096964A1) covering fluid emulsion compositions with a UV-absorbing system, surfactant system, and thickening system. The compositions include at least one physical UV-attenuating material designed for topical applications. The application classifies under CPC codes A61K 8/27 and A61Q 17/04 (skin sunscreen preparations).

Cosmetics manufacturers, skincare product developers, and UV-protective formulation companies should review the published claims to identify potential overlaps with their own R&D pipelines and product portfolios. While patent applications do not immediately restrict market access, issued claims could impact future product development strategies and may require licensing negotiations.

What to do next

  1. Monitor for patent grant status
  2. Review claims for potential IP conflicts with existing products
  3. Consult IP counsel if overlap identified

Archived snapshot

Apr 9, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

Emulsions Containing a UV-Absorbing System Including Physical UV-Attenuating Material, Surfactant, and Thickener

Application US20260096964A1 Kind: A1 Apr 09, 2026

Assignee

L'OREAL

Inventors

ANIL SHAH, DAVID ENOCH GEE, II, BRIAN BODNAR, MARGARET KINDSCHUH

Abstract

The present disclosure relates to fluid emulsion compositions including a UV absorbing system (component) including at least one physical ultraviolet (UV)-attenuating material, a surfactant system (component) including at least one surfactant, and a thickening system, as well as to methods of making and using such compositions.

CPC Classifications

A61K 8/27 A61Q 17/04 A61K 2800/30 A61K 2800/413 A61K 2800/48 A61K 2800/62

Filing Date

2024-10-04

Application No.

18906424

View original document →

Get daily alerts for USPTO Patent Applications - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260096964A1

Who this affects

Applies to
Manufacturers Healthcare providers Retailers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent filing IP licensing Cosmetic formulation
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Consumer Protection Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.